IP Library › Assignment 064404/0538
Patent Assignment
Reel/Frame 064404/0538

Change of Name

Recorded: 2023-07-27 Pages: 12
Assignor
SHENZHEN LINGFANG BIOTECH CO., LTD
Executed: 2023-04-28
Assignee
WUXI LIFE FOUNTAIN BIOTECH CO., LTD
ROOM 504, BUILDING C1, 201 LINGHU AVENUE, XINWU DISTRICT, WUXI CITY, JIANGSU PROVINCE, 214111, CHINA
Covered Property (1)
Azaindole Derivative and Use Thereof as Fgfr and C-Met Inhibitor
Application: 17/261,460 →
Publication: US 2021/0253571
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 20, 2021
From: ZHANG, YANG; CHEN, ZHENGXIA; WANG, YIKAI; DAI, MEIBI
To: MEDSHINE DISCOVERY INC.
Reel/Frame 054964/0173 →
Assignment of Assignor's Interest Jun 27, 2022
From: MEDSHINE DISCOVERY INC.
To: SHENZHEN LINGFANG BIOTECH CO., LTD
Reel/Frame 060320/0182 →